MAPK3 and metabolic dysfunction-associated steatotic liver disease: According to the bioinformatics results and studies [24, 27, 30], differentially expressed genes were enriched in the MAPK signaling pathway, while the ERK1 and ERK2 cascades were upregulated in the NAFLD group.